Novolog Injection, Solution
Product Images NDC 0169-3303

Product Visual Gallery

This gallery contains 71 technical images submitted to the FDA as part of the official labeling for Novolog (NDC 0169-3303). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Novo Nordisk, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Fig. 1 (Structural Formula of Insulin Aspart)

Chemical structure diagram showing the amino acid sequences of the A-chain and B-chain of insulin aspart, highlighting specific cysteine linkages and the sequence arrangement of each chain's amino acids.*

FDA Label Image

Fig. 2 (Pharmacodynamics Graph showing Maximum Glucose-Lowering Effect of NovoLog)

A line graph showing serum glucose levels (mg/dL) over time (hours) up to 6 hours. Two curves are plotted, one solid and one dashed, indicating changes in glucose concentrations across the time period, with serum glucose ranging from 0 to 300 mg/dL on the vertical axis and time from 0 to 6 hours on the horizontal axis.*

FDA Label Image

Fig. 3 (Pharmacodynamics Graph)

A line graph depicting mean blood glucose levels (mg/dL) over time in minutes, covering a timeline from before dosing (negative minutes) to after dosing (positive minutes), with error bars indicating variability. The X-axis shows time relative to R (dose time), and the Y-axis shows glucose concentration, illustrating glucose changes in response to the drug.*

FDA Label Image

Fig. 4 (Pharmacokinetics Graph showing Bioavailability and Absorption of NovoLog)

A line graph showing free serum insulin levels (mU/L) over time (hours). The y-axis represents free serum insulin concentration from 0 to 80 mU/L, and the x-axis shows time from 0 to 6 hours. Two lines compare different insulin concentration profiles over the time course.*

FDA Label Image

Flextouch Qr (Image 05)

An illustration depicting a vial with labels pointing to a tamper resistant cap on top and a rubber stopper located under the cap. The vial is shown as a simple line drawing without additional product text.*

FDA Label Image

Flextouch Cover (Image 06)

An instructional illustration showing a hand holding a small vial, likely to depict how to hold or handle an injection vial. The image is relevant for injectable drug products such as NOVOLOG insulin aspart solution.*

FDA Label Image

Vial Figure (Image 07)

An instructional illustration depicting hand positions for manipulating a vial. The figure shows two frames labeled Figure A and Figure B, each illustrating a hand gripping or turning the vial's cap or top, likely demonstrating vial opening or preparation steps.*

FDA Label Image

Hand And Vial Figure (Image 08)

An instructional illustration showing a hand holding a vial and syringe, with an arrow indicating drawing fluid from the vial into the syringe. The inset highlights the syringe filled with solution, demonstrating the process for preparing an injection of Novolog (insulin aspart) solution.*

FDA Label Image

Figure A And Figure B (Image 09)

Illustration showing hands holding a syringe and vial, depicting the preparation of an injection dose, likely for administration of insulin aspart solution.*

FDA Label Image

Figure C (Image 10)

An instructional illustration showing the correct method to attach a needle to a syringe by holding the syringe barrel and twisting the needle onto it. The image is labeled as Figure E and depicts a step in preparing an injection.*

FDA Label Image

Figure D (Image 11)

Illustration showing a hand holding a vial upside down and attaching or withdrawing liquid with a syringe from the vial, indicated by a downward arrow. The image demonstrates the preparation step for drawing medication from a vial.*

FDA Label Image

Figure E (Image 12)

An instructional illustration labeled Figure G showing the preparation of an injection. The image depicts a hand holding a vial upside down while withdrawing medication into a syringe held by the other hand, demonstrating the step of drawing up injection solution.*

FDA Label Image

Figure F (Image 13)

An instructional illustration showing a person holding a vial and drawing liquid with a syringe, indicating the step to pull the syringe plunger upwards. An inset shows a close-up of the syringe barrel with measurement markings. The figure is labeled "Figure H."*

FDA Label Image

Figure G (Image 14)

An instructional illustration showing a hand holding a syringe and a vial, with an arrow indicating the motion to draw medication from the vial into the syringe. This likely demonstrates the preparation of a drug injection such as insulin aspart (NOVOLOG).*

FDA Label Image

Figure H (Image 15)

Illustration showing front and back views of a human figure indicating recommended injection sites for NovoLog insulin aspart solution. Highlighted areas include the abdomen, upper legs (thighs), and buttocks, representing common subcutaneous injection locations.*

FDA Label Image

Figure I (Image 16)

An instructional illustration labeled 'Figure K' showing hands preparing an injection syringe. One hand holds the syringe while the other hand is using a needle cap removal or attachment technique, indicating a step in medication administration preparation.*

FDA Label Image

Figure J (Image 17)

An instructional diagram showing a hand holding a syringe with a needle inserted into a forearm for subcutaneous injection. An arrow indicates the upward movement of the syringe plunger to administer the injection.*

FDA Label Image

Figure K (Image 18)

Illustration showing components of NovoFine, NovoFine Plus, and NovoTwist needles, including outer and inner needle caps, needle, and paper tab. Also depicted is a PenFill cartridge compatible insulin delivery device with parts labeled: pen cap, cartridge holder, threaded end for needle attachment, colored band, rubber plunger, dose pointer, dose counter, and dose selector/dose button. An example 3 mL PenFill cartridge is included.*

FDA Label Image

Figure L (Image 19)

An instructional illustration showing a hand holding a pen-like injector with a labeled "Threaded end." The image appears to depict how to hold or identify parts of the injection device for NOVOLOG insulin aspart injection.*

FDA Label Image

Overview (FlexTouch Pen)

An instructional illustration showing hand positioning for attaching or detaching a syringe. A syringe is held by one hand, and an injectable pen or vial is held by the other, with a directional arrow indicating movement toward the pen or vial.*

FDA Label Image

Figure B (Image 21)

An instructional illustration comparing two types of insulin pen needles: NovoFine/NovoFine Plus and NovoTwist. The images depict the proper way to attach each needle type to an insulin pen device, highlighting the differences in attachment mechanisms between the two needles.*

FDA Label Image

Figure C (Image 22)

An instructional diagram comparing the use of NovoFine Plus and NovoTwist needles, showing hand placement and the process of handling or attaching the needles for injection use with NovoLog insulin aspart injection solution.*

FDA Label Image

Figure D (Image 23)

An instructional diagram showing the proper attachment of a needle to the NovoFine or NovoFine Plus and NovoTwist injection devices for administering Novolog insulin aspart injection solution.*

FDA Label Image

Figure E (Image 24)

NOVOLOG injection, solution vial featuring a thin, curved dispensing needle attached to a blue-capped container. The label appears primarily blue with white elements, indicating a 1 mL/mL, 100 [iU]/mL strength formulation of insulin aspart by Novo Nordisk. The image shows the vial with its needle but does not provide readable text details.*

FDA Label Image

Figure F (Image 25)

An instructional diagram illustrating a dose selector mechanism. It shows a dose pointer on a dial set to 12 units, with hands turning the dial to select a specific dose. The image highlights the dose counter, dose selector, and dose pointer parts of the device.*

FDA Label Image

Figure G (Image 26)

An instructional diagram showing recommended injection sites for a medication. The labeled areas include upper arms, abdomen, upper thighs, and buttocks on a simplified human figure, with a close-up inset highlighting the buttocks region.*

FDA Label Image

Figure H (Image 27)

An instructional illustration showing a hand holding an injection pen against an arm, with a speech bubble instructing to count slowly: 1-2-3-4-5-6. The image likely demonstrates the correct injection technique for administering medication subcutaneously using a pen device.*

FDA Label Image

Figure I (Image 28)

An instructional illustration showing the steps to attach a needle cap to a syringe pen device. The image uses arrows to indicate the direction of attaching the needle cap onto the device.*

FDA Label Image

Figure J (Image 29)

An instructional illustration showing hands holding a cartridge holder with a needle cap, demonstrating how to twist the needle cap off by turning it in the indicated direction. The illustration is related to preparing an injection device for use.*

FDA Label Image

Figure K (Image 30)

An instructional illustration showing a hand holding a filled syringe, with a downward arrow indicating direction toward a vial or needle. The image likely demonstrates a step in preparing or administering an injection.*

FDA Label Image

Figure L (Image 31)

Illustration showing components of needles for NovoFine, NovoFine Plus, and NovoTwist pen needles, including outer needle cap, inner needle cap, needle, and paper tab. Also shown is a labeled NovoLog FlexTouch insulin injection pen with pen cap, insulin scale, insulin window, dose counter, dose selector, dose pointer, and dose button.*

FDA Label Image

Figure M (Image 32)

An instructional illustration depicting two hands with a finger pricked to draw blood. This image likely shows the fingerstick blood sampling method for glucose monitoring or injection site preparation related to insulin use.*

FDA Label Image

Figure N (Image 33)

An illustration showing a hand holding a syringe pen-type injector with an orange needle cap, likely depicting the administration of an injectable solution such as insulin aspart (NovoLog). The image focuses on the proper handling of the injector device for subcutaneous or intravenous injection.*

FDA Label Image

Figure O (Image 34)

An instructional diagram showing how to handle two types of injection pen needles labeled NovoFine/NovoFine Plus and NovoTwist. It illustrates fingers gripping and presumably attaching or twisting the needles on a device with directional arrows indicating the motion required for each needle type.*

FDA Label Image

Figure P (Image 35)

Illustration showing the use instructions for NovoFine, NovoFine Plus, and NovoTwist injection needles. The left panel demonstrates detaching the needle from the syringe by twisting while holding the needle, and the right panel shows removal of the needle cap by twisting it off the needle hub.*

FDA Label Image

Figure Q (Image 36)

An instructional illustration showing two types of pen needle attachments for injection devices: NovoFine/NovoFine Plus and NovoTwist. It depicts how to connect each type, with arrows indicating the direction to attach the needle onto the pen device.*

FDA Label Image

Figure R (Image 37)

An instructional illustration comparing the use of NovoFine/NovoFine Plus and NovoTwist needle attachments for injections. The diagrams show hands preparing to attach or detach needles from an insulin pen device, highlighting two different needle types used with NovoLog insulin aspart injection.*

FDA Label Image

Figure S (Image 38)

An instructional illustration showing the dial of a NovoLog insulin pen set to 2 units for dosage measurement. A hand grips the pen while the dose window displays the selected 2-unit dose, indicating how to adjust and read the insulin dose prior to injection.*

FDA Label Image

Figure T (Image 39)

An instructional illustration showing a hand pressing the top of an insulin pen to release a droplet. The pen is shown vertically with an orange-tinted cartridge visible inside the device. The image suggests activation or priming of the insulin injection pen before use.*

FDA Label Image

Novolog Flexpen, Novofine, Novofine Plus And Novotwist Needles (Image 40)

An instructional diagram showing a hand holding a NovoLog insulin aspart injection pen with the cap being pulled off upward. The pen is orange and blue, with a clear view of the injection needle at the top. An inset highlights the needle tip, emphasizing the removal of the protective cap before use.*

FDA Label Image

Figure A: Components Of Cartridge And Needles (Image 41)

An instructional diagram showing the use of a dosage selector on a NovoLog insulin aspart injection pen. It illustrates how to adjust the dose with a dial, with examples displaying 5 units and 24 units selected on the dosage window. The image depicts hands turning the dosage knob and the shape of the indicator window on the pen.*

FDA Label Image

A (Preparing the NovoLog FlexPen)

An instructional illustration showing a close-up view of an orange insulin pen cartridge with a visible dose window indicating approximate insulin units left, labeled as "Example Approx. 200 units left." The pen includes a measurement scale for dosing and a blue dial at the bottom.*

FDA Label Image

Attaching The Needle (Image 43)

An instructional illustration showing front and back views of a human torso highlighting specific injection sites for NovoLog insulin aspart injection solution. Areas include the abdomen, upper arms, thighs, and buttocks, indicating acceptable subcutaneous injection locations.*

FDA Label Image

Pulling Off The Big Outer Needle Cap (Image 44)

An instructional illustration showing a hand holding a Novolog insulin pen upright with an arrow pointing downward, likely demonstrating how to hold or prepare the pen for injection or use.*

FDA Label Image

Pulling Off The Inner Needle Cap (Image 45)

An instructional illustration demonstrating the injection technique for a prefilled syringe. It shows a hand holding a syringe at an angle, inserting the needle into the skin of the arm with an indication to push downward. An icon with a zero and a downward arrow is also present, likely indicating needle insertion depth or injection action.*

FDA Label Image

E (Giving the airshot before each injection- Turn the dose selector to select 2 units)

An instructional illustration showing a hand holding a syringe with orange liquid inside, accompanied by a speech bubble instructing to "Count slowly: 1-2-3-4-5-6." This likely demonstrates a step in preparing or administering an injection, such as drawing up insulin aspart.*

FDA Label Image

F (Giving the airshot before each injection)

An instructional illustration showing a syringe or pen device with an upward-pointing arrow indicating the action of pulling up or removing. The device appears to have an orange body with a small needle or tip at the end, likely related to preparing for injection.*

FDA Label Image

G (Giving the airshot before each injection)

An instructional illustration showing two methods to remove caps from a NovoLog insulin pen. The left side demonstrates the NovoFine and NovoFine Plus needle caps being twisted off counterclockwise, while the right side shows the NovoTwist needle cap being pulled upwards to remove.*

FDA Label Image

H (Selecting the dose)

An instructional illustration showing the assembly of a needle onto an insulin pen. It depicts an arrow pointing towards the needle and insulin pen tip, indicating the direction to attach the needle. The style is simple and clear for user guidance.*

FDA Label Image

I (Giving the injection)

An instructional illustration showing a hand peeling back a protective cap from a small cylindrical object, possibly a needle or pen cap. The image highlights the peeling motion with an arrow pointing to the left, indicating removal.*

FDA Label Image

J (Giving the injection)

FDA Label Image

K (After the injection)

Label for NovoLog FlexTouch insulin aspart injection, solution. The label features the NovoLog FlexTouch brand name with a note to read before first use. The product is a human prescription drug by Novo Nordisk, supplied as 1 mL/mL, 100 units/mL for subcutaneous and intravenous administration.*

FDA Label Image

Figure B: Check The Penfill Cartridge. (Image 53)

Illustration showing components of the NovoLog FlexPen injection device and three types of needle attachments: NovoFine, NovoFine Plus, and NovoTwist. Each needle type includes parts labeled as big outer needle cap, inner needle cap, needle, and protective tab. The FlexPen main body parts include pen cap, rubber stopper, cartridge, cartridge scale, dose pointer selector, and push-button.*

FDA Label Image

Novolog Vial (Image 54)

An instructional illustration showing the initial step to prepare the NovoLog insulin aspart injection. It depicts a hand pulling off the protective cap from a NovoLog injection pen before use.*

FDA Label Image

Novolog Penfill Carton (Image 55)

An instructional illustration showing how to twist the NovoFine or NovoFine Plus needle cap prior to injection. The two-panel image demonstrates hand positioning and the twisting motion required to remove the needle cap from the syringe or injection pen, relevant to insulin aspart administration with the Novo Nordisk product set.*

FDA Label Image

Novolog Flexpen Carton (Image 56)

An instructional illustration showing how to use a NovoFine or NovoFine Plus needle and a NovoTwist needle. The left side depicts attaching a NovoFine or NovoFine Plus needle to a syringe, and the right side shows attaching a NovoTwist needle, with arrows indicating the direction for attachment.*

FDA Label Image

Novolog Flextouch Carton (Image 57)

Instructional illustration showing how to use NovoFine and NovoFine Plus needles and NovoTwist needles with insulin syringes. It depicts hands holding the syringes with demonstration arrows to indicate the proper method of attaching or handling the needles.*

FDA Label Image

Figure C: Insert The Cartridge. (Image 58)

An instructional illustration showing a hand adjusting a NovoLog insulin pen to deliver 2 units of insulin aspart by turning a dosage selector. A close-up inset highlights the pen display indicating the selected dose.*

FDA Label Image

Figure D: Push The Needle On. (Image 59)

An instructional illustration showing a hand holding a vial and gently tapping or flicking its side, indicated by motion lines. The image likely demonstrates proper handling or preparation of an injection vial, relevant to subcutaneous or intravenous administration.*

FDA Label Image

Figure E: Pull Off The Outer Needle Cap. (Image 60)

Instructional illustration showing a hand holding an injection pen device, demonstrating the removal of the cap by pulling it upwards. A smaller inset image shows the pen device without the cap, exposing the needle section, indicating preparation for injection.*

FDA Label Image

Figure F: Pull Off The Inner Needle Cap. (Image 61)

An instructional illustration showing a dosing dial on a pen injector for NOVOLOG insulin aspart injection solution. It depicts how to select a dose, with separate insets demonstrating a 5-unit dose and a 24-unit dose selected by turning the dial. The image highlights dose selection for subcutaneous or intravenous injection using the pen device.*

FDA Label Image

Figure I: Injection Sites (Image 62)

Instructional illustration showing a hand removing a protective cap from a NOVOLOG insulin aspart injection vial. The close-up detail highlights the cap removal process, indicating it is part of preparation steps for subcutaneous or intravenous administration.*

FDA Label Image

Figure J: Count Slowly. (Image 63)

An instructional illustration showing the administration of an injection using a pen device. The image depicts the injection needle penetrating the skin surface at a right angle, indicating the technique for subcutaneous or intravenous injection.*

FDA Label Image

Image 64

An instructional illustration showing a step in using a NovoLog insulin aspart injection pen. It depicts a hand holding the pen and an arrow indicating the motion of turning the dose knob or preparing the pen for injection, emphasizing the correct method to operate the device for subcutaneous or intravenous injection.*

FDA Label Image

Figure J: Lead The Needle Tip Into The Outer Cap. (Image 65)

The image shows packaging for NovoLog (insulin aspart) injection, a 100 units/mL (U-100) human prescription drug in a 10 mL multi-dose vial. It indicates intravenous or subcutaneous administration and highlights use with a U-100 syringe. Manufactured by Novo Nordisk, the label includes storage instructions, contact information, and a barcode.*

FDA Label Image

Figure K: Unscrew The Needle. (Image 66)

NovoLog (insulin aspart) injection 100 units/mL (U-100), 10 mL multiple dose vial. The packaging includes usage instructions for intravenous or subcutaneous use, warnings about refrigeration and disposal, and manufacturer information for Novo Nordisk. The label states it is for prescription use only and restricted to retail sale by Walmart and its affiliates.*

FDA Label Image

Figure L: Put The Cap On The Device. (Image 67)

NovoLog PenFill insulin aspart injection label for 100 units/mL (U-100) strength. The packaging is for a 3 mL cartridge used with Novo Nordisk delivery devices. It includes storage instructions, usage warnings, manufacturer information (Novo Nordisk), and a barcode. The label specifies the product is for single patient use only.*

FDA Label Image

Figure G: Insulin Squirts. (Image 68)

Packaging label for NovoLog FlexPen Prefilled Syringe containing insulin aspart injection. The label shows a 100 unit (1.0mL) prefilled syringe for subcutaneous use, manufactured by Novo Nordisk. The label includes dosing instructions, storage conditions, and warnings, indicating it is for single-patient use only and should be refrigerated before first use.*

FDA Label Image

Figure H: Select Your Dose. (Image 69)

Packaging label for NovoLog FlexTouch insulin aspart injection, a 100 units/mL (U-100) solution supplied in 3 mL prefilled pens. The label indicates use for subcutaneous or intravenous injection, includes dosing and storage warnings, and shows the Novo Nordisk logo. The design features images of the pen device and dosage window on a blue and white background with orange accents.*

FDA Label Image

Image 70

Packaging label for Insulin Diluting Medium for NovoLog, a 10 mL multiple-dose vial. The label notes use only with NovoLog and states that the product does not contain insulin. It includes storage and usage instructions, a barcode, and the Novo Nordisk logo. NDC 0169-2001-90 is shown on the label.*

FDA Label Image

Image 71

Packaging label for NovoLog FlexPen Prefilled Syringe, containing insulin aspart injection at 100 units/mL strength in a 3 x 3 mL prefilled syringe format. The label displays the brand and generic names, usage route (subcutaneous), storage instructions, and safety warnings. Labeler is Novo Nordisk. The product is indicated for single-patient use and includes barcode and regulatory information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.